ArticleFrontiers in transplantation2024

Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience.

Deepika Razia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.